Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Chad Cherington"'
Autor:
Kathryn Barr, Fadi Shamoun, Donald E. Morisky, Ryan McLemore, Farouk Mookadam, Chad Cherington, Stephen S. Cha, Robyn M. Scherber, Salma I. Patel
Publikováno v:
Journal of Osteopathic Medicine. 117:7-15
Context: Direct oral anticoagulants (DOACs) may be as effective as, and at times safer than, warfarin. Because DOACs do not require regular serum level monitoring, patients’ interaction with the health care system may be reduced. To the authors’
Autor:
Chad Cherington, Alan H. Bryce
Publikováno v:
Melanoma management. 2(4)
Publikováno v:
Expert Opinion on Orphan Drugs. 3:1085-1096
Introduction: The myeloproliferative neoplasm, polycythemia vera (PV) significantly impacts the quality of life of afflicted patients. The traditional therapies of phlebotomy, aspirin and cytoreductive medicines center on decreasing the risk of vascu
Autor:
Madappa N. Kundranda, Steven R. Schuster, Riccardo Valdez, Ruben A. Mesa, Chad Cherington, Donald W. Northfelt
Publikováno v:
American Journal of Hematology. 88:518-521
An 82-year-old male presented to the emergency department with an acute onset of chest pain and mild shortness of breath at rest. The pain in his left lower chest was pleuritic with intensity 9- on a 10-point scale. He had driven 2 h in his car that
Autor:
Chad Cherington, Ruben A. Mesa, Jane Olsen, Meagan S. Higgins, Roberta H. Adams, Veena Fauble, Jose F. Leis, Pierre Noel, Lisa D. Tremblay, James L. Slack, Jeffrey Betcher, John K. Camoriano, Raoul Tibes, Mary E Peterson, Ginger Gillette-Kent, Craig B. Reeder, Joseph R. Mikhael
Publikováno v:
Leukemia Research. 36:1147-1151
The prognosis for patients with Philadelphia-negative myeloproliferative neoplasms (MPN) who evolve into acute myeloid leukemia (AML) or blast phase (MPN-BP) is extremely poor. Although allogeneic stem cell transplantation (allo-SCT) is considered po
Publikováno v:
Journal of Clinical Oncology. 34:e16071-e16071
e16071Chronic kidney disease (CKD) after serial intravenous contrast exposure in patients who have had nephrectomy for kidney tumors.Background: Risk of CKD after long-term repetitive intravenous c...
Publikováno v:
Journal of Clinical Oncology. 34:353-353
353 Background: One mechanism leading to castrate-resistant prostate cancer (CRPC) is upregulation of CYP17. Abiraterone acetate (AA) inhibits CYP17 and continuous AA administration (CAAA) is one the most common and effective CRPC treatments. Mathema
Publikováno v:
Journal of Clinical Oncology. 34:624-624
624 Background: The risk of intravenous contrast induced nephropathy (CIN) is not well described in post-nephrectomy or metastatic kidney cancer. Patients with nephrectomies and tumors of the kidney frequently have CKD and often require serial contra
Autor:
Eryn M Anderson, Ryan S. Robetorye, Jody D Gunderson, Chad Cherington, Trisha L Beuschel, Riccardo Valdez, Marie J. (Jay) Maningo-Salinas
Publikováno v:
Blood. 118:4743-4743
Abstract 4743 Background: BMBX procedures are traditionally performed by physicians, NPs, or PAs using a manual method. It is uncommon for nurses to perform these procedures, and even more rare for nurses to perform them using non-traditional techniq
Autor:
Roberta H. Adams, Jose F. Leis, James L. Slack, Chad Cherington, Pierre Noel, John K. Camoriano, Raoul Tibes, Jane Olsen, Jeffrey Betcher, Ruben A. Mesa, Mary E Peterson, Meagan S. Higgins, Joseph R. Mikhael, Lisa D. Tremblay, Ginger Gillette-Kent, Craig B. Reeder
Publikováno v:
Blood. 118:1749-1749
Abstract 1749 BACKGROUND: We have previously reported that transformation of a myeloproliferative neoplasm (MPN) to acute leukemia or blast phase (MPN-BP) is accompanied by a median survival of 2.6 months (range 0–24.2 months) (Mesa et. al. Blood 2